Human Drugs View

Product Information BR-1047_PI_01.pdf
Registration Number BR-1047
Generic Name Agalsidase Beta
Brand Name Fabrazyme
Dosage Strength 5 mg
Dosage Form Powder for Concentrate for Solution for Infusion (IV)
Classification Prescription (Rx) Drug
Pharmacologic Category Enzyme
Packaging 5 mL capacity Type I clear and colorless glass vial with gray chlorobutyl rubber stopper and aluminum crimp seal (Box of 1's).
Manufacturer Genzyme Ireland Limited
Country of Origin Ireland
Trader
Importer Sanofi-Aventis Philippines, Inc..
Distributor Sanofi-Aventis Philippines, Inc..
Application Type Initial (from Monitored Release)
Issuance Date 13 September 2024
Expiry Date 13 September 2029